IDE161

· IDEAYA Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDE161, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors [Phase 1]